trending Market Intelligence /marketintelligence/en/news-insights/trending/vjre_hyopij5u6l574xoua2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Canntab Therapeutics director resigns

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Canntab Therapeutics director resigns

Canntab Therapeutics Ltd. said Sheldon Inwentash resigned from its board to pursue other opportunities.

The Canada-based company develops advanced pharmaceutical-grade formulations of cannabinoids.